Information
16-25 Dongbaekjungang-ro 16beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea
-
-
-
Overview
- Summary
- L&K Biomed is a global medical device company established in 2008, specializing in spinal implants for treating various spinal disorders. The company possesses a comprehensive production system capable of manufacturing implants for cervical, thoracic, and lumbar spine conditions. Its core focus includes the development of height-adjustable expandable cages and pectus excavatum implants. Leveraging innovative technology and a broad product portfolio, it aims to lead the global spinal medical device market. The company is dedicated to developing products that enhance patient quality of life and improve surgeon convenience.L&K Biomed is a global medical device company established in 2008, specializing in spinal implants for treating various spinal disorders. The company possesses a comprehensive production system capable of manufacturing implants for cervical, thoracic, and lumbar spine conditions. Its core focus includes the development of height-adjustable expandable cages and pectus excavatum implants. Leveraging innovative technology and a broad product portfolio, it aims to lead the global spinal medical device market. The company is dedicated to developing products that enhance patient quality of life and improve surgeon convenience.
- Key Products/Technologies
- **Expandable Cages:** PathLoc-TM is a TLIF lumbar cage system for posterior and posterolateral insertion, frequently used in spinal procedures, featuring an ergonomic design with adjustable insertion angle (up to 20 degrees), length (up to 25mm), and height (up to 4mm) to suit various patient spinal anatomies. AccelFix-XL is a lateral lumbar cage, AccelFix-XTP is a lumbar cage, and PathLoc-TA is an ALIF lumbar cage system, offering a diverse product line for various surgical approaches. The BluEX Lumbar Expandable Cage System is a new product featuring improved bone graft packing and proprietary surface technology designed to support bone integration, offering six unique cage designs suitable for a range of surgical approaches, including endoscopic spine surgery. BluEX-TM is an upgraded version of PathLoc-TM, incorporating advanced surface treatment for enhanced osseointegration and securing US FDA approval.**Expandable Cages:** PathLoc-TM is a TLIF lumbar cage system for posterior and posterolateral insertion, frequently used in spinal procedures, featuring an ergonomic design with adjustable insertion angle (up to 20 degrees), length (up to 25mm), and height (up to 4mm) to suit various patient spinal anatomies. AccelFix-XL is a lateral lumbar cage, AccelFix-XTP is a lumbar cage, and PathLoc-TA is an ALIF lumbar cage system, offering a diverse product line for various surgical approaches. The BluEX Lumbar Expandable Cage System is a new product featuring improved bone graft packing and proprietary surface technology designed to support bone integration, offering six unique cage designs suitable for a range of surgical approaches, including endoscopic spine surgery. BluEX-TM is an upgraded version of PathLoc-TM, incorporating advanced surface treatment for enhanced osseointegration and securing US FDA approval.
- **Cervical Implants:** The cervical implant product line includes CastleLoc-C for cervical interbody fusion, CastleLoc-P as an anterior cervical plate system, and CastleLoc-S as a posterior cervical fixation system. The company has a history of developing the first domestic cervical screws and obtaining FDA approval. Design patents for cervical cages, such as the XCI product, enhance the completeness of intellectual property rights.**Cervical Implants:** The cervical implant product line includes CastleLoc-C for cervical interbody fusion, CastleLoc-P as an anterior cervical plate system, and CastleLoc-S as a posterior cervical fixation system. The company has a history of developing the first domestic cervical screws and obtaining FDA approval. Design patents for cervical cages, such as the XCI product, enhance the completeness of intellectual property rights.
- **Thoracolumbar Implants and Others:** AccelFix-S is a spinal fixation screw system, AccelFix-LP is a lumbar plate system, OpenLoc-L is a spinal fixation system, and LnK Lumbar Peek Cages are part of the lumbar PEEK cage product family. PathLoc-L and AccelFix-MIS are minimally invasive spinal surgery (MIS) systems, while PathLoc-SI is an SI joint fusion system.**Thoracolumbar Implants and Others:** AccelFix-S is a spinal fixation screw system, AccelFix-LP is a lumbar plate system, OpenLoc-L is a spinal fixation system, and LnK Lumbar Peek Cages are part of the lumbar PEEK cage product family. PathLoc-L and AccelFix-MIS are minimally invasive spinal surgery (MIS) systems, while PathLoc-SI is an SI joint fusion system.
- **Pectus Excavatum Implants:** Pectus is a minimally invasive surgical product designed to improve upon the Nuss Procedure for pectus excavatum correction. It features an integrated system capable of accommodating various surgical techniques based on surgeon preference and skill during chest wall deformity surgery, thereby reducing surgical difficulty and enhancing convenience. CastleLoc Pectus has obtained US FDA approval, expanding the company's business into the thoracic treatment market.**Pectus Excavatum Implants:** Pectus is a minimally invasive surgical product designed to improve upon the Nuss Procedure for pectus excavatum correction. It features an integrated system capable of accommodating various surgical techniques based on surgeon preference and skill during chest wall deformity surgery, thereby reducing surgical difficulty and enhancing convenience. CastleLoc Pectus has obtained US FDA approval, expanding the company's business into the thoracic treatment market.
- Core Advantages
- **Innovative Height-Expandable Cage Core Technology:** The company holds a technological advantage by thoroughly analyzing and developing proprietary, patent-avoiding structures for height-expandable cages, which were previously dominated by global leaders, securing patents in both Korea and the US. This capability enables the development of over 10 types of height-expandable cage products.**Innovative Height-Expandable Cage Core Technology:** The company holds a technological advantage by thoroughly analyzing and developing proprietary, patent-avoiding structures for height-expandable cages, which were previously dominated by global leaders, securing patents in both Korea and the US. This capability enables the development of over 10 types of height-expandable cage products.
- **Customized Patient Solutions and Minimally Invasive Surgery:** Height-adjustable spinal fusion cages can be inserted at their lowest height and then adjusted to fit the intervertebral space, allowing for optimized surgical outcomes. Minimally invasive insertion reduces patient blood loss and promotes faster return to daily life.**Customized Patient Solutions and Minimally Invasive Surgery:** Height-adjustable spinal fusion cages can be inserted at their lowest height and then adjusted to fit the intervertebral space, allowing for optimized surgical outcomes. Minimally invasive insertion reduces patient blood loss and promotes faster return to daily life.
- **Strong R&D Capabilities and Strict Quality Control System:** The company has established its own infrastructure across the entire value chain, from product development to manufacturing and sales, implementing rigorous quality control at every stage from CNC machining to packaging. Product reliability is ensured through world-class quality and performance certifications, including FDA and CE marking.**Strong R&D Capabilities and Strict Quality Control System:** The company has established its own infrastructure across the entire value chain, from product development to manufacturing and sales, implementing rigorous quality control at every stage from CNC machining to packaging. Product reliability is ensured through world-class quality and performance certifications, including FDA and CE marking.
- **Strategic Approach to Global Market Expansion:** Leveraging US FDA approvals as a core foundation for direct sales in the North American market and entry into the public healthcare market through supply to Veterans Affairs hospitals. Expansion of export volume in key Asian and South American markets, including Brazil, Thailand, and Vietnam, through localized sales activities and diversification of distribution channels.**Strategic Approach to Global Market Expansion:** Leveraging US FDA approvals as a core foundation for direct sales in the North American market and entry into the public healthcare market through supply to Veterans Affairs hospitals. Expansion of export volume in key Asian and South American markets, including Brazil, Thailand, and Vietnam, through localized sales activities and diversification of distribution channels.
- **Successful Expansion into New Business Areas:** Beyond spinal implants, the company successfully entered the thoracic treatment market by developing the pectus excavatum implant 'Pectus' and obtaining US FDA approval. This contributes to product portfolio diversification and improved profitability.**Successful Expansion into New Business Areas:** Beyond spinal implants, the company successfully entered the thoracic treatment market by developing the pectus excavatum implant 'Pectus' and obtaining US FDA approval. This contributes to product portfolio diversification and improved profitability.
- **User-Centric Product Development through Close Collaboration with Medical Professionals:** Continuous collaboration with industry-leading surgeons to develop innovative and surgically optimized systems. Rapid incorporation of surgeon feedback to provide user-friendly products and enhance surgical convenience.**User-Centric Product Development through Close Collaboration with Medical Professionals:** Continuous collaboration with industry-leading surgeons to develop innovative and surgically optimized systems. Rapid incorporation of surgeon feedback to provide user-friendly products and enhance surgical convenience.
- Target Industrie
- Medical Device IndustryMedical Device Industry
- OrthopedicsOrthopedics
- NeurosurgeryNeurosurgery
- Spinal Disease TreatmentSpinal Disease Treatment
- Thoracic Deformity SurgeryThoracic Deformity Surgery
- Major Markets
- South Korea, Thailand, Vietnam, India, China, Japan, Taiwan, Hong KongSouth Korea, Thailand, Vietnam, India, China, Japan, Taiwan, Hong Kong
- EuropeEurope
- United StatesUnited States
- Brazil, Mexico, ChileBrazil, Mexico, Chile
- Certifications/Patents
- **U.S. Patents:** Patent for height-adjustable spinal fusion cage (acquired September 5, 2022). U.S. Patent "Height-adjustable spinal fusion cage" (Patent No. 12,491,079, issued December 9, 2025). U.S. patent related to 'Rotary Blade Type' spinal plate (subsidiary Aegis Spine Inc., acquired September 30, 2021). Fundamental patent and circumvention patents for height-expandable interbody fusion devices (cages) (acquired December 21, 2020). Design patent for cervical cages (related to XCI products, acquired July 30, 2021). Patent for cage holder of spinal fusion cage (acquired June 30, 2022).**U.S. Patents:** Patent for height-adjustable spinal fusion cage (acquired September 5, 2022). U.S. Patent "Height-adjustable spinal fusion cage" (Patent No. 12,491,079, issued December 9, 2025). U.S. patent related to 'Rotary Blade Type' spinal plate (subsidiary Aegis Spine Inc., acquired September 30, 2021). Fundamental patent and circumvention patents for height-expandable interbody fusion devices (cages) (acquired December 21, 2020). Design patent for cervical cages (related to XCI products, acquired July 30, 2021). Patent for cage holder of spinal fusion cage (acquired June 30, 2022).
- **U.S. FDA Approvals:** PathLoc-TM (next-generation height-expandable spinal implant, approved March 14, 2022). AccelFix Lumbar Expandable Cage System (AccelFix-XT, AccelFix-XTP, AccelFix-XL, approved September 16, 2019). BluEX Lumbar Expandable Cage System (approved October 29, 2024). BluEX-TM (new version of PathLoc-TM, approved July 8, 2025). Six types of 'BluEX Series' (lumbar height-expandable cages, approved October 23, 2024). Pectus (pectus excavatum implant, approved April 25, 2025, CastleLoc Pectus). PathLoc Lumbar Plate System (new spinal implant, approved March 12, 2026). First domestic cervical screw.**U.S. FDA Approvals:** PathLoc-TM (next-generation height-expandable spinal implant, approved March 14, 2022). AccelFix Lumbar Expandable Cage System (AccelFix-XT, AccelFix-XTP, AccelFix-XL, approved September 16, 2019). BluEX Lumbar Expandable Cage System (approved October 29, 2024). BluEX-TM (new version of PathLoc-TM, approved July 8, 2025). Six types of 'BluEX Series' (lumbar height-expandable cages, approved October 23, 2024). Pectus (pectus excavatum implant, approved April 25, 2025, CastleLoc Pectus). PathLoc Lumbar Plate System (new spinal implant, approved March 12, 2026). First domestic cervical screw.
- **Other Certifications and Awards:** CE Marking (essential certification for European market entry). Brazil ANVISA registration in progress (5 types of height-expandable cages). Nobel Science Award for Science and Technology (Chairman Kang Gook-jin, December 23, 2022). Seoul National University Bundang Hospital's Best Technology Commercialization Partner Appreciation Plaque (December 11, 2024). 2021 Korea Global Crown Award, Medical Sector Corporate Award (March 4, 2021).**Other Certifications and Awards:** CE Marking (essential certification for European market entry). Brazil ANVISA registration in progress (5 types of height-expandable cages). Nobel Science Award for Science and Technology (Chairman Kang Gook-jin, December 23, 2022). Seoul National University Bundang Hospital's Best Technology Commercialization Partner Appreciation Plaque (December 11, 2024). 2021 Korea Global Crown Award, Medical Sector Corporate Award (March 4, 2021).
Introduction
Location
16-25 Dongbaekjungang-ro 16beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
